RADA-PonG1 merges a self-assembling RADA motif with a functional PonG1 segment, enabling formation of nanofibers that present bioactive sites. Alternating charged and hydrophobic residues drive β-sheet assembly. Researchers investigate its supramolecular organization and cell-interaction properties. Applications include biomaterial design, peptide-hydrogel development, and scaffolded bioactive presentation.
CAT No: R2730
RADA-PonG1, a synthetic carbohydrate-peptide hybrid, represents a significant advancement in the field of biomaterials and molecular engineering. Featuring a self-assembling peptide backbone with strategically incorporated carbohydrate moieties, RADA-PonG1 exhibits unique physicochemical properties that enable its use in a variety of research and technological domains. Its modular structure and biocompatibility make it particularly attractive for applications requiring precise molecular interactions and customizable surface characteristics. Researchers value RADA-PonG1 for its ability to form stable nanostructures under physiological conditions, facilitating the development of innovative platforms for both fundamental studies and applied sciences. The integration of glycosylated motifs into the RADA peptide scaffold enhances its functionality, supporting diverse applications ranging from material science to cell biology. Its tunable assembly and interaction capabilities contribute to its growing popularity in multidisciplinary research settings.
Tissue Engineering Scaffolds: RADA-PonG1 is widely utilized in the fabrication of three-dimensional scaffolds for tissue engineering research. By leveraging its inherent self-assembling properties, scientists can create hydrogels and matrices that mimic the extracellular environment, supporting cell adhesion, proliferation, and differentiation. The presence of carbohydrate groups within the peptide framework enables enhanced cell-matrix interactions, making it suitable for studies focused on regenerating complex tissues such as cartilage, nerve, and skin. These scaffolds provide a customizable platform for investigating cell behavior, matrix remodeling, and tissue integration, offering valuable insights into regenerative medicine and biomaterials science.
Controlled Drug Delivery Systems: In the domain of drug delivery, RADA-PonG1 serves as a promising carrier for the encapsulation and sustained release of bioactive molecules. Its ability to assemble into nanofibrous networks allows for the incorporation of therapeutic agents, which can then be released in a controlled manner in response to environmental triggers. The carbohydrate components facilitate specific interactions with target cells or tissues, potentially enhancing the localization and efficacy of delivered compounds. Researchers employ RADA-PonG1-based delivery systems to study pharmacokinetics, drug stability, and targeted delivery mechanisms, contributing to the advancement of precision medicine and therapeutic research.
Cell Culture Substrates: As a cell culture substrate, RADA-PonG1 provides a biologically relevant and tunable surface for in vitro studies. Its peptide-carbohydrate composition supports the attachment and growth of a variety of cell types, including stem cells and primary cultures. By modulating the density and presentation of carbohydrate motifs, scientists can investigate the effects of microenvironmental cues on cell signaling, morphology, and differentiation. This application is particularly valuable for high-throughput screening, mechanistic studies of cell-matrix interactions, and the development of advanced cell-based assays for drug discovery and toxicology research.
Biosensor Development: The unique molecular architecture of RADA-PonG1 makes it an excellent candidate for biosensor construction. Its self-assembling nature allows for the formation of ordered nanostructures on sensor surfaces, while the carbohydrate elements provide specific binding sites for analytes such as proteins, pathogens, or small molecules. By incorporating RADA-PonG1 into sensor platforms, researchers can achieve enhanced sensitivity and selectivity in the detection of biological targets. This application supports the development of diagnostic tools for environmental monitoring, food safety, and biomedical analysis, where rapid and accurate detection is essential.
Biomimetic Surface Coatings: RADA-PonG1 is also employed to engineer biomimetic coatings for a variety of research and industrial applications. Its ability to form stable, functionalized layers on diverse substrates enables the modification of surface properties such as hydrophilicity, biocompatibility, and resistance to fouling. The carbohydrate-peptide hybrid structure allows for the presentation of bioactive motifs, facilitating interactions with cells, proteins, or other biomolecules. These coatings are instrumental in the study of cell-surface interactions, the development of anti-fouling materials, and the creation of platforms for biospecific recognition in analytical devices. Collectively, the versatility and molecular precision of RADA-PonG1 continue to drive innovation across multiple scientific disciplines, making it an indispensable tool for researchers seeking to bridge the gap between molecular design and functional application.
1. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More